ARBs "suitable alternative" in chronic heart failure

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1469, 2005-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Valsartan: In Chronic Heart Failure

By Wellington K. Goa K.L.

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 4, 2002-01 ,pp. : 267-274

Adis International

Access to resources Recommend Favorite

Cardiovascular Outcomes in High-Risk Patients without Heart Failure Treated with ARBs: A Systematic Review and Meta-Analysis

By Khalaf Mohamad M. Al

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 1, 2009-01 ,pp. : 29-43

Adis International

Access to resources Recommend Favorite

Pharmacologic Therapy of Chronic Heart Failure

By Hamad Eman Mather Paul J. Srinivasan Siva Rubin Sharon Whellan David J. Feldman Arthur M.

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 4, 2007-01 ,pp. : 235-248

Adis International

Access to resources Recommend Favorite

Carvedilol in the treatment of chronic heart failure

By Moe G.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 5, 2001-05 ,pp. : 831-843

Informa Healthcare

Access to resources Recommend Favorite

Neuroimmune Activation in Chronic Heart Failure

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 13, Iss. 1, 2013-03 ,pp. : 68-75

Bentham Science Publishers

Access to resources Recommend Favorite